Covid-19-Related Severe Heterogeneous Acute Respiratory Distress Syndrome: A Therapeutic Challenge

Covid-19-Related Severe Heterogeneous Acute Respiratory Distress Syndrome: A Therapeutic Challenge Publisher

Jamaati H¹ ; Fadaizadeh L² ; Khoundabi B³ ; Hashemian S¹ ; Monjazabi F⁴ ; Jahangirifard A¹ ; Beigmohammadi M⁵ ; Farzanegan B⁶ ; Shojaei S⁷ ; Tabarsi P⁸ ; Dastan F^{1, 9} ; Reza Nadji S¹⁰ ; Toutkaboni M¹¹ ; Malekmohammad M⁶ Show All Authors

Jamaati H¹
Fadaizadeh L²
Khoundabi B³
Hashemian S¹
Monjazabi F⁴
Jahangirifard A¹
Beigmohammadi M⁵
Farzanegan B⁶
Shojaei S⁷
Tabarsi P⁸
Dastan F^{1, 9}
Reza Nadji S¹⁰
Toutkaboni M¹¹
Malekmohammad M⁶
Mohamadnia A¹
Mortaz E¹²
Mirenayat M¹³
Yassari F¹⁴
Heshmatnia J¹⁴
Eslaminejad A¹
Velayati A¹⁵

Source: Biomedical and Biotechnology Research Journal Published:2020

Abstract

Background: A heterogeneous pattern was detected in COVID-19 severe acute respiratory distress syndrome (ARDS) patients. The aim of this study was to define special features and individualized treatment modalities for this fatal infectious disease. Methods: Thirty-six patients diagnosed as COVID-19 severe ARDS were chosen. Lung mechanics (compliance), the extravascular lung water index (EVLWI) and pulmonary vascular permeability index (PVPI), and serum concentrations of immunology markers (interleukin [IL]-1β, IL-6, IL-8, ferritin, and C-reactive protein) were measured. Accordingly, individualized treatment consisting of Actemra, hemoperfusion (HP), continuous renal replacement therapy (CRRT), and extracorporeal membrane oxygenation (ECMO) was implemented for each patient. Results: Patients were categorized according to the lung compliance: 18 in 'L type' with compliance >40 cc/cmH2O and 18 in 'H type' with compliance ≤40 cc/cmH2O. In 16 patients, standard mechanical ventilation management and antiviral therapy were unsuccessful; therefore, hemodynamic and immunity responses were evaluated. Results of transpulmonary thermodilution in L-type patients surprisingly showed EVLWI = 8.8 ± 1.3 (6.9-9.7) and PVPI = 2.4 ± 0.1 (2.2-2.6). In the H-type patients, five cases showed EVLWI = 8.7 ± 0.8 (7.5-9.8) and PVPI = 2.6 ± 0.3 (2.1-2.8) which were subclassified as 'Ha type' and five cases with EVLWI = 17.5 ± 1.9 (15.7-20.6) and PVPI = 3.9 ± 0.4 (3.5-4.5) were named 'Hb type'. By measuring immunologic markers, these two groups were subdivided into high and low marker groups. Individualized treatment resulted in 2 survivals with Actemra, 1 with HP, 2 with HP + CRRT, and 1 with ECMO. Conclusion: According to the heterogeneity of COVID-19 severe ARDS presentation, which is due to various immunologic and hemodynamic responses, a systematic approach is an important and relatively successful strategy in choosing the appropriate treatment modality. © 2020 Medknow.

Related Docs

View other Related Docs

1. Early Hemoperfusion for Cytokine Removal May Contribute to Prevention of Intubation in Patients Infected With Covid-19, Blood Purification (2021)

2. Immunomodulatory-Based Therapy As a Potential Promising Treatment Strategy Against Severe Covid-19 Patients: A Systematic Review, International Immunopharmacology (2020)

3. The Immune System and Covid-19: Friend or Foe?, Life Sciences (2020)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (3)

Ehsan Bastanhagh (1)

Style	Citing Format
MLA	Jamaati H, et al.. "Covid-19-Related Severe Heterogeneous Acute Respiratory Distress Syndrome: A Therapeutic Challenge." Biomedical and Biotechnology Research Journal, vol. 4, no. 5, 2020, pp. S75-S82.
APA	Jamaati H, Fadaizadeh L, Khoundabi B, Hashemian S, Monjazabi F, Jahangirifard A, Beigmohammadi M, Farzanegan B, Shojaei S, Tabarsi P, Dastan F, Reza Nadji S, Toutkaboni M, Malekmohammad M, Mohamadnia A, Mortaz E, Mirenayat M, Yassari F, Heshmatnia J, ... Velayati A (2020). Covid-19-Related Severe Heterogeneous Acute Respiratory Distress Syndrome: A Therapeutic Challenge. Biomedical and Biotechnology Research Journal, 4(5), S75-S82.
Chicago	Jamaati H, Fadaizadeh L, Khoundabi B, Hashemian S, Monjazabi F, Jahangirifard A, Beigmohammadi M, et al.. "Covid-19-Related Severe Heterogeneous Acute Respiratory Distress Syndrome: A Therapeutic Challenge." Biomedical and Biotechnology Research Journal 4, no. 5 (2020): S75-S82.
Harvard	Jamaati H et al. (2020) 'Covid-19-Related Severe Heterogeneous Acute Respiratory Distress Syndrome: A Therapeutic Challenge', Biomedical and Biotechnology Research Journal, 4(5), pp. S75-S82.
Vancouver	Jamaati H, Fadaizadeh L, Khoundabi B, Hashemian S, Monjazabi F, Jahangirifard A, et al.. Covid-19-Related Severe Heterogeneous Acute Respiratory Distress Syndrome: A Therapeutic Challenge. Biomedical and Biotechnology Research Journal. 2020;4(5):S75-S82.
BibTex	@article{ author = {Jamaati H and Fadaizadeh L and Khoundabi B and Hashemian S and Monjazabi F and Jahangirifard A and Beigmohammadi M and Farzanegan B and Shojaei S and Tabarsi P and Dastan F and Reza Nadji S and Toutkaboni M and Malekmohammad M and Mohamadnia A and Mortaz E and Mirenayat M and Yassari F and Heshmatnia J and Eslaminejad A and Velayati A}, title = {Covid-19-Related Severe Heterogeneous Acute Respiratory Distress Syndrome: A Therapeutic Challenge}, journal = {Biomedical and Biotechnology Research Journal}, volume = {4}, number = {5}, pages = {S75-S82}, year = {2020} }
RIS	TY - JOUR AU - Jamaati H AU - Fadaizadeh L AU - Khoundabi B AU - Hashemian S AU - Monjazabi F AU - Jahangirifard A AU - Beigmohammadi M AU - Farzanegan B AU - Shojaei S AU - Tabarsi P AU - Dastan F AU - Reza Nadji S AU - Toutkaboni M AU - Malekmohammad M AU - Mohamadnia A AU - Mortaz E AU - Mirenayat M AU - Yassari F AU - Heshmatnia J AU - Eslaminejad A AU - Velayati A TI - Covid-19-Related Severe Heterogeneous Acute Respiratory Distress Syndrome: A Therapeutic Challenge JO - Biomedical and Biotechnology Research Journal VL - 4 IS - 5 SP - S75 EP - S82 PY - 2020 ER -

Style

Citing Format

MLA

Jamaati H, et al.. "Covid-19-Related Severe Heterogeneous Acute Respiratory Distress Syndrome: A Therapeutic Challenge." Biomedical and Biotechnology Research Journal, vol. 4, no. 5, 2020, pp. S75-S82.

APA

Jamaati H, Fadaizadeh L, Khoundabi B, Hashemian S, Monjazabi F, Jahangirifard A, Beigmohammadi M, Farzanegan B, Shojaei S, Tabarsi P, Dastan F, Reza Nadji S, Toutkaboni M, Malekmohammad M, Mohamadnia A, Mortaz E, Mirenayat M, Yassari F, Heshmatnia J, ... Velayati A (2020). Covid-19-Related Severe Heterogeneous Acute Respiratory Distress Syndrome: A Therapeutic Challenge. Biomedical and Biotechnology Research Journal, 4(5), S75-S82.

Chicago

Jamaati H, Fadaizadeh L, Khoundabi B, Hashemian S, Monjazabi F, Jahangirifard A, Beigmohammadi M, et al.. "Covid-19-Related Severe Heterogeneous Acute Respiratory Distress Syndrome: A Therapeutic Challenge." Biomedical and Biotechnology Research Journal 4, no. 5 (2020): S75-S82.

Harvard

Jamaati H et al. (2020) 'Covid-19-Related Severe Heterogeneous Acute Respiratory Distress Syndrome: A Therapeutic Challenge', Biomedical and Biotechnology Research Journal, 4(5), pp. S75-S82.

Vancouver

Jamaati H, Fadaizadeh L, Khoundabi B, Hashemian S, Monjazabi F, Jahangirifard A, et al.. Covid-19-Related Severe Heterogeneous Acute Respiratory Distress Syndrome: A Therapeutic Challenge. Biomedical and Biotechnology Research Journal. 2020;4(5):S75-S82.

BibTex

@article{ author = {Jamaati H and Fadaizadeh L and Khoundabi B and Hashemian S and Monjazabi F and Jahangirifard A and Beigmohammadi M and Farzanegan B and Shojaei S and Tabarsi P and Dastan F and Reza Nadji S and Toutkaboni M and Malekmohammad M and Mohamadnia A and Mortaz E and Mirenayat M and Yassari F and Heshmatnia J and Eslaminejad A and Velayati A}, title = {Covid-19-Related Severe Heterogeneous Acute Respiratory Distress Syndrome: A Therapeutic Challenge}, journal = {Biomedical and Biotechnology Research Journal}, volume = {4}, number = {5}, pages = {S75-S82}, year = {2020} }

RIS

TY - JOUR
AU - Jamaati H
AU - Fadaizadeh L
AU - Khoundabi B
AU - Hashemian S
AU - Monjazabi F
AU - Jahangirifard A
AU - Beigmohammadi M
AU - Farzanegan B
AU - Shojaei S
AU - Tabarsi P
AU - Dastan F
AU - Reza Nadji S
AU - Toutkaboni M
AU - Malekmohammad M
AU - Mohamadnia A
AU - Mortaz E
AU - Mirenayat M
AU - Yassari F
AU - Heshmatnia J
AU - Eslaminejad A
AU - Velayati A
TI - Covid-19-Related Severe Heterogeneous Acute Respiratory Distress Syndrome: A Therapeutic Challenge
JO - Biomedical and Biotechnology Research Journal
VL - 4
IS - 5
SP - S75
EP - S82
PY - 2020
ER -

Science Communicator Platform

Authors

Abstract